| Future of cancer incidence in the United States: burdens upon an aging, changing nation BD Smith, GL Smith, A Hurria, GN Hortobagyi, TA Buchholz Journal of clinical oncology 27 (17), 2758-2765, 2009 | 1945 | 2009 |
| Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JC Boughey, VJ Suman, EA Mittendorf, GM Ahrendt, LG Wilke, B Taback, ... Jama 310 (14), 1455-1461, 2013 | 1604 | 2013 |
| Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy HM Kuerer, LA Newman, TL Smith, FC Ames, KK Hunt, K Dhingra, ... Journal of Clinical Oncology 17 (2), 460-460, 1999 | 1564 | 1999 |
| Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in … AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, ... Journal of clinical oncology 23 (16), 3676-3685, 2005 | 1505 | 2005 |
| Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) BD Smith, DW Arthur, TA Buchholz, BG Haffty, CA Hahn, PH Hardenbergh, ... International Journal of Radiation Oncology* Biology* Physics 74 (4), 987-1001, 2009 | 1153 | 2009 |
| American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer HJ Burstein, AA Prestrud, J Seidenfeld, H Anderson, TA Buchholz, ... Journal of Clinical Oncology 28 (23), 3784-3796, 2010 | 1010 | 2010 |
| Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update HJ Burstein, S Temin, H Anderson, TA Buchholz, NE Davidson, ... Journal of clinical oncology 32 (21), 2255-2269, 2014 | 989 | 2014 |
| WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells WA Woodward, MS Chen, F Behbod, MP Alfaro, TA Buchholz, JM Rosen Proceedings of the National Academy of Sciences 104 (2), 618-623, 2007 | 776 | 2007 |
| Cyclin E and survival in patients with breast cancer K Keyomarsi, SL Tucker, TA Buchholz, M Callister, YE Ding, ... New England Journal of Medicine 347 (20), 1566-1575, 2002 | 749 | 2002 |
| Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors V Guarneri, K Broglio, SW Kau, M Cristofanilli, AU Buzdar, V Valero, ... Journal of clinical oncology 24 (7), 1037-1044, 2006 | 745 | 2006 |
| Risk of cardiac death after adjuvant radiotherapy for breast cancer SH Giordano, YF Kuo, JL Freeman, TA Buchholz, GN Hortobagyi, ... Journal of the National Cancer Institute 97 (6), 419-424, 2005 | 673 | 2005 |
| Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype WF Symmans, C Wei, R Gould, X Yu, Y Zhang, M Liu, A Walls, ... Journal of Clinical Oncology 35 (10), 1049-1060, 2017 | 627 | 2017 |
| Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update HJ Burstein, C Lacchetti, H Anderson, TA Buchholz, NE Davidson, ... Journal of Clinical Oncology 37 (5), 423-438, 2019 | 626 | 2019 |
| Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor … AU Buzdar, V Valero, NK Ibrahim, D Francis, KR Broglio, RL Theriault, ... Clinical Cancer Research 13 (1), 228-233, 2007 | 601 | 2007 |
| High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ... Journal of clinical oncology 27 (34), 5700-5706, 2009 | 564 | 2009 |
| Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study YCT Shih, Y Xu, JN Cormier, S Giordano, SH Ridner, TA Buchholz, ... Journal of clinical oncology 27 (12), 2007-2014, 2009 | 564 | 2009 |
| International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011 | 553 | 2011 |
| Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation A Katz, EA Strom, TA Buchholz, HD Thames, CD Smith, A Jhingran, ... Journal of clinical oncology 18 (15), 2817-2827, 2000 | 520 | 2000 |
| Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer R Rouzier, R Rajan, P Wagner, KR Hess, DL Gold, J Stec, M Ayers, ... Proceedings of the National Academy of Sciences 102 (23), 8315-8320, 2005 | 514 | 2005 |
| Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience AM Chen, F Meric-Bernstam, KK Hunt, HD Thames, MJ Oswald, ... Journal of Clinical Oncology 22 (12), 2303-2312, 2004 | 487 | 2004 |
Wendy WoodwardProfessor, MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
